Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
The launch coincides with IBS Awareness Month in April
A brand from Opella will be part of the official NASA astronaut formulary
The company announced positive topline data from the Phase II ZUPREME-1 trial
BRAFTOVI in combination with cetuximab and mFOLFOX6 had previously received accelerated approval in December 2024 based on objective response rate (ORR) results
The trial targeted a patient population with high BMI and extensive skin involvement, averaging over 39 kg/m²
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
